Back to Search
JACOB FORBES, DO
DO
Family Medicine Physician
NPI: 1841819794IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
7293(OK)1329004-1204(UT)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2020
Research & Publications (20)
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
PMID 19474112·Ann Oncol·2009
3-trial
Oxidative stress as a major culprit in kidney disease in diabetes.
PMID 18511445·Diabetes·2008
6-review
A personal view of how ruminant animals control their intake and choice of food: minimal total discomfort.
PMID 19079866·Nutr Res Rev·2007
8-other
Diabetic nephropathy: where hemodynamics meets metabolism.
PMID 17318765·Exp Clin Endocrinol Diabetes·2007
6-review
Multimodal imaging of the sonic organ of Porichthys notatus, the singing midshipman fish.
PMID 16563962·Magn Reson Imaging·2006
7-preclinical
Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?
PMID 16648883·Clin Biochem Rev·2005
8-other
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
PMID 15930093·J Am Soc Nephrol·2005
7-preclinical
The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes.
PMID 15485399·Kidney Int Suppl·2004
6-review
Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy.
PMID 15544521·Curr Pharm Des·2004
6-review
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.
PMID 15220206·Diabetes·2004
7-preclinical
The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.
PMID 12958202·FASEB J·2003
7-preclinical
Role of advanced glycation end products in diabetic nephropathy.
PMID 12874442·J Am Soc Nephrol·2003
6-review
Consequences of feeding for future feeding.
PMID 11246038·Comp Biochem Physiol A Mol Integr Physiol·2001
6-review
Gastrointestinal fistulae in chronic granulomatous disease.
PMID 19436280·Am J Gastroenterol·2009
5-case
Nanomechanics of full-length nebulin: an elastic strain gauge in the skeletal muscle sarcomere.
PMID 19463013·Langmuir·2009
7-preclinical
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer.
PMID 19553291·Ann Oncol·2009
3-trial
A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches?
PMID 19556753·Am J Nephrol·2009
6-review
Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study.
PMID 19628355·J Vasc Surg·2009
8-other
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus.
PMID 19349317·Circulation·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4 E Clark Bass Blvd Ste 301
McAlester, OK 74501 - Phone
- (918) 421-6081
Quick Facts
- NPI
- 1841819794
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile